AAAAAA

   
Results: 1-25 | 26-47
Results: 1-25/47
LIPID ABNORMALITIES IN STABLE LIVER-TRANSPLANT RECIPIENTS - EFFECTS OF CYCLOSPORINE, TACROLIMUS, AND STEROIDS
Authors: FERNANDEZMIRANDA C GUIJARRO C DELACALLE A LOINAZ C GONZALEZPINTO I GOMEZIZQUIERDO T LARUMBE S MORENO E DELPALACIO A
Citation: C. Fernandezmiranda et al., LIPID ABNORMALITIES IN STABLE LIVER-TRANSPLANT RECIPIENTS - EFFECTS OF CYCLOSPORINE, TACROLIMUS, AND STEROIDS, Transplant international, 11(2), 1998, pp. 137-142
LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE STUDY. (VOL 12, PG 136, 1998)
Authors: FERNANDEZMIRANDA C DELACALLE A MORALES JM GUIJARRO C ARANDA JL GOMEZSANZ R GOMEZIZQUIERDO T LARUMBE S MORENO E RODICIO JL DELPALACIO A
Citation: C. Fernandezmiranda et al., LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE STUDY. (VOL 12, PG 136, 1998), Clinical transplantation, 12(5), 1998, pp. 487-487
LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE-STUDY
Authors: FERNANDEZMIRANDA C DELACALLE A MORALES JM GUIJARRO C ARANDA JL GOMEZSANZ R GOMEZIZQUIERDO T LARUMBE S MORENO E RODICIO JL DELPALACIO A
Citation: C. Fernandezmiranda et al., LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE-STUDY, Clinical transplantation, 12(2), 1998, pp. 136-141
LOVASTATIN REDUCES GLOMERULAR MACROPHAGE INFLUX AND EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN NEPHROTIC RATS
Authors: PARK YS GUIJARRO C KIM Y MASSY ZA KASISKE BL KEANE WF ODONNELL MP
Citation: Ys. Park et al., LOVASTATIN REDUCES GLOMERULAR MACROPHAGE INFLUX AND EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN NEPHROTIC RATS, American journal of kidney diseases, 31(1), 1998, pp. 190-194
HYPERLIPIDEMIA AS A PATHOGENIC FACTOR IN CHRONIC PROGRESSIVE RENAL-FAILURE
Authors: GUIJARRO C MASSY ZA
Citation: C. Guijarro et Za. Massy, HYPERLIPIDEMIA AS A PATHOGENIC FACTOR IN CHRONIC PROGRESSIVE RENAL-FAILURE, Nefrologia, 18, 1998, pp. 23-29
3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE AND ISOPRENYLATION INHIBITORS INDUCE APOPTOSIS OF VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE
Authors: GUIJARRO C BLANCOCOLIO LM ORTEGO M ALONSO C ORTIZ A PLAZA JJ DIAZ C HERNANDEZ G EGIDO J
Citation: C. Guijarro et al., 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE AND ISOPRENYLATION INHIBITORS INDUCE APOPTOSIS OF VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE, Circulation research, 83(5), 1998, pp. 490-500
LIPOPROTEIN CHANGES IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITHINTERFERON-ALPHA
Authors: FERNANDEZMIRANDA C CASTELLANO G GUIJARRO C FERNANDEZ I SCHOEBEL N LARUMBE S GOMEZIZQUIERDO T DELPALACIO A
Citation: C. Fernandezmiranda et al., LIPOPROTEIN CHANGES IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED WITHINTERFERON-ALPHA, The American journal of gastroenterology, 93(10), 1998, pp. 1901-1904
INCREASED LIPOPROTEINS AND FIBRINOGEN IN CHRONIC RENAL-ALLOGRAFT DYSFUNCTION
Authors: FERNANDEZMIRANDA C MORALES JM PORRES A GOMEZGERIQUE J GUIJARRO C ARANDA JL ANDRES A RODICIO JL DELPALACIO A
Citation: C. Fernandezmiranda et al., INCREASED LIPOPROTEINS AND FIBRINOGEN IN CHRONIC RENAL-ALLOGRAFT DYSFUNCTION, American journal of nephrology, 17(5), 1997, pp. 445-449
LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE-STUDY
Authors: FERNANDEZMIRANDA C DELACALLE A MORALES JM GUIJARRO C ARANDA JL GOMEZ T LARUMBE S MORENO E RODICIO JL PALACIO A
Citation: C. Fernandezmiranda et al., LIPOPROTEIN ABNORMALITIES IN LONG-TERM STABLE LIVER AND RENAL TRANSPLANTED PATIENTS - A COMPARATIVE-STUDY, Atherosclerosis, 134(1-2), 1997, pp. 43-43
ATORVASTATIN INHIBITION OF NF-KAPPA-B ACTIVATION IN VASCULAR SMOOTH-MUSCLE CELLS IS MEDIATED BY PROTEIN ISOPRENYLATION BLOCKADE
Authors: ORTEGO M BUSTOS C HERNANDEZPRESA M GUIJARRO C TUNON J EGIDO J
Citation: M. Ortego et al., ATORVASTATIN INHIBITION OF NF-KAPPA-B ACTIVATION IN VASCULAR SMOOTH-MUSCLE CELLS IS MEDIATED BY PROTEIN ISOPRENYLATION BLOCKADE, Atherosclerosis, 134(1-2), 1997, pp. 131-131
ATORVASTATIN REDUCES LESION SIZE AND MACROPHAGE CONTENT IN A RABBIT MODEL OF ATHEROSCLEROSIS, AND ATTENUATES NF-KAPPA-B ACTIVATION AND MCP-1 EXPRESSION IN CULTURED VSMC
Authors: BUSTOS C HERNANDEZPRESA MA ORTEGO M TUNON J ORTEGA L GUIJARRO C DIAZ C HERNANDEZ G EGIDO J
Citation: C. Bustos et al., ATORVASTATIN REDUCES LESION SIZE AND MACROPHAGE CONTENT IN A RABBIT MODEL OF ATHEROSCLEROSIS, AND ATTENUATES NF-KAPPA-B ACTIVATION AND MCP-1 EXPRESSION IN CULTURED VSMC, Atherosclerosis, 130, 1997, pp. 23-23
HMG-COA REDUCTASE INHIBITION BY ATORVASTATIN (ATV) INDUCES APOPTOSIS OF VASCULAR SMOOTH-MUSCLE CELLS (VSMC) IN CULTURE - ROLE OF ISOPRENOIDS OF THE MEVALONATE PATHWAY
Authors: GUIJARRO C ORTEGO M ORTIZ A HERNANDEZPRESA MA BUSTOS C DIAZ C HERNANDEZ G EGIDO J
Citation: C. Guijarro et al., HMG-COA REDUCTASE INHIBITION BY ATORVASTATIN (ATV) INDUCES APOPTOSIS OF VASCULAR SMOOTH-MUSCLE CELLS (VSMC) IN CULTURE - ROLE OF ISOPRENOIDS OF THE MEVALONATE PATHWAY, Atherosclerosis, 130, 1997, pp. 24-24
ATORVASTATIN ABOLISHES MACROPHAGE INFILTRATION, AND REDUCES NEOINTIMAL FORMATION AND MCP-1 EXPRESSION IN A RABBIT MODEL OF ATHEROSCLEROSIS - ROLE OF NUCLEAR FACTOR KAPPA-B
Authors: HERNANDEZPRESA MA BUSTOS C ORTEGO M TUNON J GUIJARRO C DIAZ C HERNANDEZ G EGIDO J
Citation: Ma. Hernandezpresa et al., ATORVASTATIN ABOLISHES MACROPHAGE INFILTRATION, AND REDUCES NEOINTIMAL FORMATION AND MCP-1 EXPRESSION IN A RABBIT MODEL OF ATHEROSCLEROSIS - ROLE OF NUCLEAR FACTOR KAPPA-B, Circulation, 96(8), 1997, pp. 1621-1621
RELAPSE OF TUBERCULOSIS AFTER TREATMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
Authors: PULIDO F PENA JM RUBIO R MORENO S GONZALEZ J GUIJARRO C COSTA JR VAZQUEZ JJ
Citation: F. Pulido et al., RELAPSE OF TUBERCULOSIS AFTER TREATMENT IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Archives of internal medicine, 157(2), 1997, pp. 227-232
EFFECTS OF NATIVE AND OXIDIZED (OX) LOW-DENSITY-LIPOPROTEIN (LDL) ON MESANGIAL CELL EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND INTERLEUKIN-6 (IL-6) - MODULATION BY LOVASTATIN
Authors: MASSY ZA GUIJARRO C KASISKE B ODA H KEANE WF KIM Y ODONNELL MP
Citation: Za. Massy et al., EFFECTS OF NATIVE AND OXIDIZED (OX) LOW-DENSITY-LIPOPROTEIN (LDL) ON MESANGIAL CELL EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) AND INTERLEUKIN-6 (IL-6) - MODULATION BY LOVASTATIN, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3063-3063
CARDIOVASCULAR-DISEASE AFTER RENAL-TRANSPLANTATION
Authors: KASISKE BL GUIJARRO C MASSY ZA WIEDERKEHR MR MA JZ
Citation: Bl. Kasiske et al., CARDIOVASCULAR-DISEASE AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 7(1), 1996, pp. 158-165
LOVASTATIN INHIBITS LIPOPOLYSACCHARIDE-INDUCED NF-KAPPA-B ACTIVATION IN HUMAN MESANGIAL CELLS
Authors: GUIJARRO C KIM Y SCHOONOVER CM MASSY ZA ODONNELL MP KASISKE BL KEANE WF KASHTAN CE
Citation: C. Guijarro et al., LOVASTATIN INHIBITS LIPOPOLYSACCHARIDE-INDUCED NF-KAPPA-B ACTIVATION IN HUMAN MESANGIAL CELLS, Nephrology, dialysis, transplantation, 11(6), 1996, pp. 990-996
EFFECTS OF LIPIDS ON THE PATHOGENESIS OF PROGRESSIVE RENAL-FAILURE - ROLE OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS IN THE PREVENTION OF GLOMERULOSCLEROSIS
Authors: GUIJARRO C KEANE WF
Citation: C. Guijarro et Wf. Keane, EFFECTS OF LIPIDS ON THE PATHOGENESIS OF PROGRESSIVE RENAL-FAILURE - ROLE OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITORS IN THE PREVENTION OF GLOMERULOSCLEROSIS, Mineral and electrolyte metabolism, 22(1-3), 1996, pp. 147-152
SERUM-ALBUMIN AND MORTALITY AFTER RENAL-TRANSPLANTATION
Authors: GUIJARRO C MASSY ZA WIEDERKEHR MR MA JZ KASISKE BL
Citation: C. Guijarro et al., SERUM-ALBUMIN AND MORTALITY AFTER RENAL-TRANSPLANTATION, American journal of kidney diseases, 27(1), 1996, pp. 117-123
CHRONIC RENAL-ALLOGRAFT REJECTION - IMMUNOLOGICAL AND NONIMMUNOLOGICAL RISK-FACTORS
Authors: MASSY ZA GUIJARRO C WIEDERKEHR MR MA JZ KASISKE BL
Citation: Za. Massy et al., CHRONIC RENAL-ALLOGRAFT REJECTION - IMMUNOLOGICAL AND NONIMMUNOLOGICAL RISK-FACTORS, Kidney international, 49(2), 1996, pp. 518-524
EXPRESSION OF LEUKOCYTE CHEMOATTRACTANTS BY INTERSTITIAL RENAL FIBROBLASTS - UP-REGULATION BY DRUGS ASSOCIATED WITH INTERSTITIAL FIBROSIS
Authors: GONZALEZCUADRADO S BUSTOS C RUIZORTEGA M ORTIZ A GUIJARRO C PLAZA JJ EGIDO J
Citation: S. Gonzalezcuadrado et al., EXPRESSION OF LEUKOCYTE CHEMOATTRACTANTS BY INTERSTITIAL RENAL FIBROBLASTS - UP-REGULATION BY DRUGS ASSOCIATED WITH INTERSTITIAL FIBROSIS, Clinical and experimental immunology, 106(3), 1996, pp. 518-522
BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF
Authors: MASSY ZA KASISKE BL GUIJARRO C KIM Y KEANE WF ODONNELL MP
Citation: Za. Massy et al., BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF, Journal of the American Society of Nephrology, 6(3), 1995, pp. 800-800
WHY CYCLOSPORINE (CSA) PREVENTS ACUTE REJECTION (AREJ) WITHOUT PREVENTING CHRONIC ALLOGRAFT-REJECTION (CREJ) AFTER RENAL-TRANSPLANTATION
Authors: MASSY ZA GUIJARRO C WIEDERKEHR MR MA JZ KASISKE BL
Citation: Za. Massy et al., WHY CYCLOSPORINE (CSA) PREVENTS ACUTE REJECTION (AREJ) WITHOUT PREVENTING CHRONIC ALLOGRAFT-REJECTION (CREJ) AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1104-1104
EARLY GLOMERULAR CHANGES IN RATS WITH DIETARY-INDUCED HYPERCHOLESTEROLEMIA
Authors: GUIJARRO C KASISKE BL KIM YK ODONNELL MP LEE HS KEANE WF
Citation: C. Guijarro et al., EARLY GLOMERULAR CHANGES IN RATS WITH DIETARY-INDUCED HYPERCHOLESTEROLEMIA, American journal of kidney diseases, 26(1), 1995, pp. 152-161
ISOPRENOIDS AND RAS - POTENTIAL ROLE IN CHRONIC REJECTION
Authors: ODONNELL MP KASISKE BL MASSY ZA GUIJARRO C SWAN SK KEANE WF
Citation: Mp. Odonnell et al., ISOPRENOIDS AND RAS - POTENTIAL ROLE IN CHRONIC REJECTION, Kidney international, 48, 1995, pp. 29-33
Risultati: 1-25 | 26-47